The page is the record's research on the issuer — no analyst, no rating, no view. # Ernexa Therapeutics Inc. (NASDAQ: ERNA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Ernexa Therapeutics Inc., listed on NASDAQ under the ticker ERNA. The ISIN is not on the record. The LEI is not on the record. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 53 filings in the twelve months to 2026-11-08, across 34 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-06 and is of type results, 2 days before the record date. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, and the NASDAQ median filings count is 52. The NASDAQ median latency is 5.0 days. The 2834 Pharmaceutical Preparations median cadence gap is 6.0 days across 526 issuers, the median filings count is 63.0, and the median latency is 4.0 days. ## Auditor The auditor of record is HASKELL & WHITE LLP, located in Irvine, California. The record holds no auditor changes. ## Events and halts The record holds two listing lines, both dated 2026-02-05. No delisting, name change, domicile change, or segment move lines are on the record; the domicile change and segment move are not on the record. The halt flag is listed, not halted. ## Orderability The outcome is not determinable under the US reasonable-basis suitability rule, FINRA Rule 2111, because the chapter's orderability section names no client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0000748592.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ERNA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/748592/000149315226010102/form10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ERNA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ERNA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp